Israel’s Teva has received FDA approval for ProAir RespiClick – the first and only breath-actuated, dry-powder rescue inhaler to be approved by the FDA for the treatment of acute asthma symptoms. ProAir RespiClick eliminates the need for hand-breath coordination during inhalation.
http://www.globes.co.il/en/article-teva-asthma-treatment-receives-fda-approval-1001025040